Model of influenza A virus infection: dynamics of viral antagonism and innate immune response.

Viral antagonism of host responses is an essential component of virus pathogenicity. The study of the interplay between immune response and viral antagonism is challenging due to the involvement of many processes acting at multiple time scales. Here we develop an ordinary differential equation model to investigate the early, experimentally measured, responses of human monocyte-derived dendritic cells to infection by two H1N1 influenza A viruses of different clinical outcomes: pandemic A/California/4/2009 and seasonal A/New Caledonia/20/1999. Our results reveal how the strength of virus antagonism, and the time scale over which it acts to thwart the innate immune response, differs significantly between the two viruses, as is made clear by their impact on the temporal behavior of a number of measured genes. The model thus sheds light on the mechanisms that underlie the variability of innate immune responses to different H1N1 viruses.

[1]  Thomas M. Moran,et al.  Influenza Virus Evades Innate and Adaptive Immunity via the NS1 Protein , 2006, Journal of Virology.

[2]  A. García-Sastre,et al.  Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[3]  S. Goodbourn,et al.  Variation in the ability of human influenza A viruses to induce and inhibit the IFN-beta pathway. , 2006, Virology.

[4]  David E. Levy,et al.  Influenza virus targets the mRNA export machinery and the nuclear pore complex , 2007, Proceedings of the National Academy of Sciences.

[5]  A. García-Sastre,et al.  The NS1 Protein of a Human Influenza Virus Inhibits Type I Interferon Production and the Induction of Antiviral Responses in Primary Human Dendritic and Respiratory Epithelial Cells , 2009, Journal of Virology.

[6]  R. Krug,et al.  Cellular antiviral responses against influenza A virus are countered at the posttranscriptional level by the viral NS1A protein via its binding to a cellular protein required for the 3' end processing of cellular pre-mRNAS. , 2003, Virology.

[7]  S. Goodbourn,et al.  Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. , 2008, The Journal of general virology.

[8]  G. Kochs,et al.  Multiple Anti-Interferon Actions of the Influenza A Virus NS1 Protein , 2007, Journal of Virology.

[9]  D. Levy,et al.  Differential viral induction of distinct interferon‐α genes by positive feedback through interferon regulatory factor‐7 , 1998, The EMBO journal.

[10]  L. Ivashkiv,et al.  TNF activates an IRF1-dependent autocrine loop leading to sustained expression of chemokines and STAT1-dependent type I interferon–response genes , 2008, Nature Immunology.

[11]  R. Albrecht,et al.  Innate immune evasion strategies of influenza viruses. , 2010, Future microbiology.

[12]  Nan Yan,et al.  Trex1 regulates lysosomal biogenesis and interferon-independent activation of antiviral genes , 2012, Nature Immunology.

[13]  C. Horvath,et al.  Nipah Virus V Protein Evades Alpha and Gamma Interferons by Preventing STAT1 and STAT2 Activation and Nuclear Accumulation , 2002, Journal of Virology.

[14]  Adolfo García-Sastre,et al.  Induction and evasion of type I interferon responses by influenza viruses. , 2011, Virus research.

[15]  A. García-Sastre,et al.  Inefficient Control of Host Gene Expression by the 2009 Pandemic H1N1 Influenza A Virus NS1 Protein , 2010, Journal of Virology.

[16]  Johannes G. Bode,et al.  Influenza A Virus Inhibits Type I IFN Signaling via NF-κB-Dependent Induction of SOCS-3 Expression , 2008, PLoS pathogens.

[17]  S. Sealfon,et al.  Interferon-β Pretreatment of Conventional and Plasmacytoid Human Dendritic Cells Enhances Their Activation by Influenza Virus , 2008, PLoS pathogens.

[18]  S. Sealfon,et al.  Novel Nipah Virus Immune-Antagonism Strategy Revealed by Experimental and Computational Study , 2010, Journal of Virology.

[19]  B. G. Hale,et al.  The multifunctional NS1 protein of influenza A viruses. , 2008, The Journal of general virology.

[20]  G. Kaplan,et al.  The distinctive features of influenza virus infection of dendritic cells. , 1998, Immunobiology.

[21]  A. García-Sastre,et al.  Nipah Virus V and W Proteins Have a Common STAT1-Binding Domain yet Inhibit STAT1 Activation from the Cytoplasmic and Nuclear Compartments, Respectively , 2004, Journal of Virology.

[22]  S. Pleschka,et al.  Apoptosis signaling in influenza virus propagation, innate host defense, and lung injury , 2012, Journal of leukocyte biology.

[23]  Boris M. Hartmann,et al.  Mouse Dendritic Cell (DC) Influenza Virus Infectivity Is Much Lower than That for Human DCs and Is Hemagglutinin Subtype Dependent , 2012, Journal of Virology.

[24]  R. Krug,et al.  Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3'end formation of cellular pre-mRNAs. , 1998, Molecular cell.

[25]  S. Sealfon,et al.  Immune response modeling of interferon beta-pretreated influenza virus-infected human dendritic cells. , 2010, Biophysical journal.

[26]  Kalyanmoy Deb,et al.  Multi-objective optimization using evolutionary algorithms , 2001, Wiley-Interscience series in systems and optimization.

[27]  Boris M. Hartmann,et al.  Antiviral-Activated Dendritic Cells: A Paracrine-Induced Response State1 , 2008, The Journal of Immunology.